세계의 말초 혈관 스텐트 임플란트 시장 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2033년)

Peripheral Stent Implants Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

US $ 4,995 ￦ 6,970,000

Unprintable PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.

US $ 7,295 ￦ 10,179,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

US $ 8,495 ￦ 11,853,000

PDF & Excel (Corporate User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

한글목차

Persistence Market Research는 최근 말초 혈관 스텐트 임플란트 세계 시장에 대한 종합적인 보고서를 발표했습니다. 본 보고서에서는 시장 성장 촉진요인, 동향, 기회, 촉진요인, 과제 등의 중요한 시장 역학을 철저히 평가하여 시장 구조에 대한 상세한 통찰을 제공합니다.

주요 인사이트

• 말초 혈관 스텐트 임플란트 시장 규모(2024E) : 41억 달러
• 예측 시장 가치(2033F) : 75억 달러
• 세계 시장 성장률(CAGR 2024년부터 2033년까지) : 6.9%

말초 혈관 스텐트 임플란트 시장 - 보고 범위:

말초 혈관 스텐트 임플란트는 다리와 팔과 같은 심장 이외의 말초 혈관계에서 협착되거나 막힌 동맥을 여는 데 사용되는 중요한 의료기기입니다. 이 스텐트는 적절한 혈류를 회복시키고 사지의 허혈과 같은 심각한 합병증을 예방합니다. 말초 혈관 스텐트 임플란트 시장은 말초 동맥 질환(PAD)의 유병률 증가, 스텐트 기술의 진보, 낮은 침습 절차에 대한 수요 증가로 인한 것입니다. 이 보고서는 베어 메탈 스텐트, 약물 용출 스텐트, 생체 흡수성 스텐트 등 다양한 유형의 스텐트와 다양한 환자층에서의 용도에 대한 통찰력을 제공합니다.

시장 성장 촉진요인:

세계의 말초 혈관 스텐트 임플란트 시장은 고령화, 당뇨병, 생활 습관과 관련된 위험 인자로 인한 PAD 발생률 증가 등 몇 가지 중요한 요인에 의해 추진되고 있습니다. 약물 용출성 스텐트와 생체 흡수성 스캐폴드의 개발 등 기술의 진보가 치료 성적을 향상시켜 시장 성장을 가속하고 있습니다. 또한 회복 시간이 짧고 합병증 발생률이 낮은 침습 수술로의 전환이 스텐트 이식의 채용을 늘리고 있습니다. 혈관의 건강 증진을 목적으로 한 정부의 대처나 헬스케어 정책도 시장 확대에 기여하고 있습니다.

시장 성장 억제요인:

유망한 성장 전망이 있음에도 불구하고, 말초 혈관 스텐트 임플란트 시장은 높은 비용과 상환 문제와 관련된 문제에 직면하고 있습니다. 최신 스텐트에 사용되는 고급 기술은 종종 높은 가격으로 이어지므로 특히 신흥 국가에서는 환자와 건강 관리 제공업체에게 장벽이 될 수 있습니다. 또한, 재협착이나 스텐트 혈전증 등의 합병증이 임상상의 과제가 되어 시장의 성장을 제한할 가능성이 있습니다. 규제상의 장애물과 신제품 승인을 뒷받침하는 장기적인 임상 데이터의 필요성도 시장 진출자에게 어려움을 겪고 있습니다.

시장 기회:

말초 혈관 스텐트 임플란트 시장은 현재 진행 중인 연구 개발, 혈관 질환에 대한 의식이 높아지고, 신흥국 시장에서 헬스케어 인프라의 확대가 큰 성장 기회를 가져오고 있습니다. 생체 적합성, 유연성 및 약물 전달 기능을 향상시킨 차세대 스텐트의 개발은 치료 성적을 향상시킬 수 있습니다. 시장 개척을 추진하는 기업은 혁신에 대한 투자, 의료 제공자와의 전략적 파트너십 구축, 환자 중심 제품 개발에 주력함으로써 이러한 기회를 활용할 수 있습니다. 맞춤형 의료에 대한 경향의 높아짐과 고도의 화상 기술의 채용도, 시장 성장의 길을 연다.

• 이 보고서에서 다루는 주요 질문
• 말초 혈관 스텐트 임플란트 시장의 세계 성장을 가속하는 주요 요인은 무엇인가?
• 다양한 환자층에서 채용을 선도하는 스텐트의 유형과 기술은?
• 기술의 진보는 말초 혈관 스텐트 임플란트 시장 경쟁 구도에 어떤 영향을 미치는가?
• 말초 혈관 스텐트 임플란트 시장에 기여하는 주요 기업은 누구이며 시장 관련성을 유지하기 위해 어떤 전략을 채택하고 있는가?
• 세계의 말초 혈관 스텐트 임플란트 시장의 새로운 동향과 전망은?

목차

제1장 주요 요약

제2장 시장 개요

• 시장 범위/분류
• 시장의 정의/범위/제한
• 포함과 제외

제3장 주요 시장 동향

• 시장에 영향을 주는 주요 동향
• 시장의 혁신/개발 동향

제4장 중요한 성공 요인

• 제조업체별 주요 프로모션 전략
• 주요 규제
• PESTEL 분석
• Porter's Five Forces 분석
• 제품 발매 활동
• 제품의 채용/사용 상황 분석
• 환불
• 밸류체인 분석

제5장 시장 배경

• 거시경제 요인
• 예측 요인- 관련성과 영향
• 시장 역학

제6장 COVID-19 위기 분석

• COVID-19와 영향 분석
• 2024년 시장 시나리오

제7장 세계 시장 규모('000 유닛) 분석

• 시장 규모('000 유닛) 분석, 2019-2023년
• 시장 규모('000 유닛) 예측, 2024-2033년
  • 전년대비 성장 동향 분석

제8장 세계 시장 - 가격 분석

• 소재별 지역별 가격 분석
• 가격 분석
  • 제조업체 레벨의 가격 설정
  • 유통업체 레벨의 가격 설정
• 세계 평균 가격 분석 벤치마크
• 가격 설정의 전제

제9장 세계 시장 수요(가치 또는 규모, 10억 달러) 분석

• 시장 매출(10억 달러)과 수량(천대) 분석, 2019-2023년
• 시장 규모(10억 달러)와 수량(천대)의 분석과 예측, 시장 분류별, 2024-2033년
  • 전년대비 성장 동향 분석
  • 절대 수익 기회

제10장 제품별 : 세계 시장 분석

• 소개/주요 조사 결과
• 시장 규모(10억 달러)와 수량(천대) 분석, 2019-2023년
• 시장 규모(10억 달러)와 수량(천대)의 분석과 예측, 2024-2033년
  • 베어 메탈 스텐트(BMS)
  • 커버 부착 스텐트
  • 약제 용출 스텐트(DES)
• 제품별 시장의 매력 분석

제11장 동맥별: 세계 시장 분석

• 소개/주요 조사 결과
• 시장 규모(10억 달러) 분석, 2019-2023년
• 시장 규모(10억 달러) 분석과 예측, 2024-2033년
  • 경동맥 스텐트
  • 대퇴 무릎 동맥 동맥 스텐트
  • 장골동맥 스텐트
  • 무릎 동맥 하동맥 스텐트
• Artery에 의한 시장의 매력 분석

제12장 최종 사용자별 세계 시장 분석

• 소개/주요 조사 결과
• 시장 규모(10억 달러) 분석, 2019-2023년
• 시장 규모(10억 달러) 분석과 예측, 2024-2033년
  • 병원
  • 외래수술센터(ASC)/외래 환자
• 최종 사용자별 시장의 매력 분석

제13장 지역별 세계 시장 분석

• 소개/주요 조사 결과
• 시장 규모(10억 달러)와 수량(천대) 분석, 2019-2023년
• 시장 규모(10억 달러)와 수량(천대)의 분석과 예측, 2024-2033년
  • 북미
  • 라틴아메리카
  • 유럽
  • 동아시아
  • 남아시아
  • 오세아니아
  • 중동 및 아프리카
• 지역별 시장의 매력 분석

제14장 북미 시장 분석

제15장 라틴아메리카 시장 분석

제16장 유럽 시장 분석

제17장 동아시아 시장 분석

제18장 남아시아 시장 분석

제19장 오세아니아 시장

제20장 중동 및 아프리카 시장 분석

제21장 시장 구조 분석

• 기업 Tier별 시장 분석
• 주요 기업의 시장 점유율 분석
• 시장현재분석

제22장 경쟁 분석

• 경쟁 대시보드
• 경쟁 벤치마킹
• 경쟁의 상세
  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Biotronik SE &Co. KG
  • Boston Scientific Corporation
  • Cook Medical, Inc.
  • Cardinal Health, Inc.
  • iVascular SLU
  • Medtronic Plc.
  • Terumo Corporation
  • WL Gore &Associates Inc.

제23장 사용된 전제조건과 약어

제24장 조사 방법

JHS

영문 목차

영문목차

Persistence Market Research has recently released a comprehensive report on the worldwide market for peripheral stent implants. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

• Peripheral Stent Implants Market Size (2024E): USD 4.1 Bn
• Projected Market Value (2033F): USD 7.5 Bn
• Global Market Growth Rate (CAGR 2024 to 2033): 6.9%

Peripheral Stent Implants Market - Report Scope:

Peripheral stent implants are vital medical devices used to open narrowed or blocked arteries in the peripheral vascular system, including the legs, arms, and other areas outside the heart. These stents help restore proper blood flow, preventing severe complications like limb ischemia. The market for peripheral stent implants is driven by the growing prevalence of peripheral artery disease (PAD), advancements in stent technology, and increasing demand for minimally invasive procedures. The report provides insights into various types of stents, such as bare-metal stents, drug-eluting stents, and bioresorbable stents, and their applications across different patient demographics.

Market Growth Drivers:

The global peripheral stent implants market is propelled by several key factors, including the rising incidence of PAD due to an aging population, diabetes, and lifestyle-related risk factors. Technological advancements, such as the development of drug-eluting stents and bioresorbable scaffolds, are enhancing treatment outcomes and driving market growth. Additionally, the shift towards minimally invasive procedures, which offer shorter recovery times and lower complication rates, is increasing the adoption of stent implants. Government initiatives and healthcare policies aimed at improving vascular health also contribute to market expansion.

Market Restraints:

Despite promising growth prospects, the peripheral stent implants market faces challenges related to high costs and reimbursement issues. The advanced technology used in modern stents often leads to higher prices, which can be a barrier for patients and healthcare providers, especially in emerging economies. Additionally, complications such as restenosis and stent thrombosis pose clinical challenges, potentially limiting market growth. Regulatory hurdles and the need for long-term clinical data to support new product approvals also present challenges for market players.

Market Opportunities:

The peripheral stent implants market presents significant growth opportunities driven by ongoing research and development, increasing awareness of vascular diseases, and expanding healthcare infrastructure in emerging markets. The development of next-generation stents with improved biocompatibility, flexibility, and drug-delivery capabilities offers potential for enhanced treatment outcomes. Market players can capitalize on these opportunities by investing in innovation, forming strategic partnerships with healthcare providers, and focusing on patient-centric product development. The growing trend towards personalized medicine and the adoption of advanced imaging technologies also create avenues for market growth.

• Key Questions Answered in the Report:
• What are the primary factors driving the growth of the peripheral stent implants market globally?
• Which types of stents and technologies are leading adoption across different patient demographics?
• How are technological advancements influencing the competitive landscape of the peripheral stent implants market?
• Who are the key players contributing to the peripheral stent implants market, and what strategies are they employing to maintain market relevance?
• What are the emerging trends and future prospects in the global peripheral stent implants market?

Competitive Intelligence and Business Strategy:

Leading players in the global peripheral stent implants market, including Boston Scientific Corporation, Abbott Laboratories, and Medtronic plc, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced stent solutions, including drug-eluting stents and bioresorbable scaffolds, catering to diverse clinical needs and regulatory standards. Collaborations with healthcare providers, research institutions, and regulatory bodies facilitate market access and promote technology adoption. Emphasis on clinical outcomes, patient safety, and cost-effectiveness drives market growth and reinforces the position of key players in the evolving vascular treatment landscape.

Key Companies Profiled:

• Abbott Laboratories
• B. Braun Melsungen AG
• Biotronik SE & Co. KG
• Boston Scientific Corporation
• Cook Medical, Inc.
• Cardinal Health, Inc.
• iVascular SLU
• Medtronic Plc.
• Terumo Corporation
• W. L. Gore & Associates Inc.

Key Segments Covered in Peripheral Stent Implants Industry Research

Product

• Bare Metal Stents (BMS)
• Covered Stents
• Drug Eluting Stents (DES)

Artery

• Carotid Artery Stents
• Fem-Pop Artery Stents
• Iliac Artery Stents
• Infrapop Artery Stents

End User

• Hospitals
• Ambulatory Surgical Centers/Outpatient

Region

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East and Africa (MEA)

Table of Contents

1. Executive Summary

• 1.1. Global Market Outlook
• 1.2. Demand Side Trends
• 1.3. Supply Side Trends
• 1.4. Analysis and Recommendations

2. Market Overview

• 2.1. Market Coverage / Taxonomy
• 2.2. Market Definition / Scope / Limitations
• 2.3. Inclusions and Exclusions

3. Key Market Trends

• 3.1. Key Trends Impacting the Market
• 3.2. Market Innovation / Development Trends

4. Key Success Factors

• 4.1. Key Promotional Strategies, by Manufacturers
• 4.2. Key Regulations
• 4.3. PESTEL Analysis
• 4.4. Porter's Analysis
• 4.5. Product Launch Activities
• 4.6. Product Adoption/Usage Analysis
• 4.7. Reimbursement
• 4.8. Value Chain Analysis

5. Market Background

• 5.1. Macro-Economic Factors
  • 5.1.1. Global GDP Growth Outlook
  • 5.1.2. Global Healthcare Outlook
  • 5.1.3. Global Peripheral Vascular Devices Outlook
• 5.2. Forecast Factors - Relevance & Impact
  • 5.2.1. Top Companies Historical Growth
  • 5.2.2. New Product Launches and Approvals
  • 5.2.3. Global Peripheral Vascular Diseases
  • 5.2.4. Research and Development Expenditure by Key Players
  • 5.2.5. Historic and Current Revenue of Key Players
  • 5.2.6. Rising Consumer Awareness of the Product
  • 5.2.7. Rising Adoption of Device Technological Development
  • 5.2.8. Strategic Developments by Key Players
  • 5.2.9. Increasing Adoption of Peripheral Vascular Devices for Various Arteries
  • 5.2.10. Strategic Collaborations among Players
• 5.3. Market Dynamics
  • 5.3.1. Drivers
  • 5.3.2. Restraints
  • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

• 6.1. COVID-19 and Impact Analysis
  • 6.1.1. By Product
  • 6.1.2. By Artery
  • 6.1.3. By End User
  • 6.1.4. By Country
• 6.2. 2024 Market Scenario

7. Global Market Volume ('000 Units) Analysis 2019-2023 and Forecast, 2024-2033

• 7.1. Historical Market Volume ('000 Units) Analysis, 2019-2023
• 7.2. Current and Future Market Volume ('000 Units) Projections, 2024-2033
  • 7.2.1. Y-o-Y Growth Trend Analysis

8. Global Market - Pricing Analysis

• 8.1. Regional Pricing Analysis By Material
• 8.2. Pricing Break-up
  • 8.2.1. Manufacturer Level Pricing
  • 8.2.2. Distributor Level Pricing
• 8.3. Global Average Pricing Analysis Benchmark
• 8.4. Pricing Assumptions

9. Global Market Demand (in Value or Size in US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033

• 9.1. Historical Market Value (US$ Bn) and Volume ('000 Units) Analysis, 2019-2023
• 9.2. Current and Future Market Size (US$ Bn) and Volume ('000 Units) Analysis and Forecast by Market Taxonomy, 2024-2033
  • 9.2.1. Y-o-Y Growth Trend Analysis
  • 9.2.2. Absolute $ Opportunity Analysis

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Product

• 10.1. Introduction / Key Findings
• 10.2. Historical Market Size (US$ Bn) and Volume ('000 Units) Analysis by Product, 2019-2023
• 10.3. Current and Future Market Size (US$ Bn) and Volume ('000 Units) Analysis and Forecast by Product, 2024-2033
  • 10.3.1. Bare Metal Stents (BMS)
  • 10.3.2. Covered Stents
  • 10.3.3. Drug Eluting Stents (DES)
• 10.4. Market Attractiveness Analysis by Product

11. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Artery

• 11.1. Introduction / Key Findings
• 11.2. Historical Market Size (US$ Bn) Analysis by Artery, 2019-2023
• 11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast by Artery, 2024-2033
  • 11.3.1. Carotid Artery Stents
  • 11.3.2. Fem-Pop Artery Stents
  • 11.3.3. Iliac Artery Stents
  • 11.3.4. Infrapop Artery Stents
• 11.4. Market Attractiveness Analysis by Artery

12. Global Market Analysis 2019-2023 and Forecast 2024-2033, By End User

• 12.1. Introduction / Key Findings
• 12.2. Historical Market Size (US$ Bn) Analysis by End User, 2019-2023
• 12.3. Current and Future Market Size (US$ Bn) Analysis and Forecast by End User, 2024-2033
  • 12.3.1. Hospitals
  • 12.3.2. Ambulatory Surgical Centers/Outpatients
• 12.4. Market Attractiveness Analysis by End User

13. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Region

• 13.1. Introduction / Key Findings
• 13.2. Historical Market Size (US$ Bn) and Volume ('000 Units) Analysis, by Region, 2019-2023
• 13.3. Current and Future Market Size (US$ Bn) and Volume ('000 Units) Analysis Forecast by Region, 2024-2033
  • 13.3.1. North America
  • 13.3.2. Latin America
  • 13.3.3. Europe
  • 13.3.4. East Asia
  • 13.3.5. South Asia
  • 13.3.6. Oceania
  • 13.3.7. Middle East & Africa
• 13.4. Market Attractiveness Analysis by Region

14. North America Market Analysis 2019-2023 and Forecast 2024-2033

• 14.1. Introduction
• 14.2. Historical Market Size (US$ Bn) and Volume ('000 Units) Analysis Trend Analysis by Market Taxonomy, 2019-2023
• 14.3. Current and Future Market Size (US$ Bn) and Volume ('000 Units) Analysis and Forecast by Market Taxonomy, 2024-2033
  • 14.3.1. By Country
    • 14.3.1.1. U.S.
    • 14.3.1.2. Canada
  • 14.3.2. By Product
  • 14.3.3. By Artery
  • 14.3.4. By End User
• 14.4. Market Attractiveness Analysis
  • 14.4.1. By Country
  • 14.4.2. By Product
  • 14.4.3. By Artery
  • 14.4.4. By End User
• 14.5. Market Trends
• 14.6. Key Market Participants - Intensity Mapping
• 14.7. Drivers and Restraints - Impact Analysis
• 14.8. Country Level Analysis & Forecast
  • 14.8.1. U.S. Market
    • 14.8.1.1. Introduction
    • 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 14.8.1.2.1. By Product
      • 14.8.1.2.2. By Artery
      • 14.8.1.2.3. By End User
  • 14.8.2. Canada Market
    • 14.8.2.1. Introduction
    • 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 14.8.2.2.1. By Product
      • 14.8.2.2.2. By Artery
      • 14.8.2.2.3. By End User

15. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

• 15.1. Introduction
• 15.2. Historical Market Size (US$ Bn) and Volume ('000 Units) Analysis Trend Analysis By Market Taxonomy, 2019-2023
• 15.3. Current and Future Market Size (US$ Bn) and Volume ('000 Units) Analysis and Forecast by Market Taxonomy, 2024-2033
  • 15.3.1. By Country
    • 15.3.1.1. Mexico
    • 15.3.1.2. Brazil
    • 15.3.1.3. Argentina
    • 15.3.1.4. Rest of Latin America
  • 15.3.2. By Product
  • 15.3.3. By Artery
  • 15.3.4. By End User
• 15.4. Market Attractiveness Analysis
  • 15.4.1. By Country
  • 15.4.2. By Product
  • 15.4.3. By Artery
  • 15.4.4. By End User
• 15.5. Market Trends
• 15.6. Key Market Participants - Intensity Mapping
• 15.7. Drivers and Restraints - Impact Analysis
• 15.8. Country Level Analysis & Forecast
  • 15.8.1. Mexico Market Analysis
    • 15.8.1.1. Introduction
    • 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.1.2.1. By Product
      • 15.8.1.2.2. By Artery
      • 15.8.1.2.3. By End User
  • 15.8.2. Brazil Market Analysis
    • 15.8.2.1. Introduction
    • 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.2.2.1. By Product
      • 15.8.2.2.2. By Artery
      • 15.8.2.2.3. By End User
  • 15.8.3. Argentina Market Analysis
    • 15.8.3.1. Introduction
    • 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.3.2.1. By Product
      • 15.8.3.2.2. By Artery
      • 15.8.3.2.3. By End User

16. Europe Market Analysis 2019-2023 and Forecast 2024-2033

• 16.1. Introduction
• 16.2. Historical Market Size (US$ Bn) and Volume ('000 Units) Analysis Trend Analysis by Market Taxonomy, 2019-2023
• 16.3. Current and Future Market Size (US$ Bn) and Volume ('000 Units) Analysis and Forecast by Market Taxonomy, 2024-2033
  • 16.3.1. By Country
    • 16.3.1.1. Germany
    • 16.3.1.2. Italy
    • 16.3.1.3. France
    • 16.3.1.4. U.K.
    • 16.3.1.5. Spain
    • 16.3.1.6. BENELUX
    • 16.3.1.7. Russia
    • 16.3.1.8. Rest of Europe
  • 16.3.2. By Product
  • 16.3.3. By Artery
  • 16.3.4. By End User
• 16.4. Market Attractiveness Analysis
  • 16.4.1. By Country
  • 16.4.2. By Product
  • 16.4.3. By Artery
  • 16.4.4. By End User
• 16.5. Market Trends
• 16.6. Key Market Participants - Intensity Mapping
• 16.7. Drivers and Restraints - Impact Analysis
• 16.8. Country Level Analysis & Forecast
  • 16.8.1. Germany Market Analysis
    • 16.8.1.1. Introduction
    • 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.1.2.1. By Product
      • 16.8.1.2.2. By Artery
      • 16.8.1.2.3. By End User
  • 16.8.2. Italy Market Analysis
    • 16.8.2.1. Introduction
    • 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.2.2.1. By Product
      • 16.8.2.2.2. By Artery
      • 16.8.2.2.3. By End User
  • 16.8.3. France Market Analysis
    • 16.8.3.1. Introduction
    • 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.3.2.1. By Product
      • 16.8.3.2.2. By Artery
      • 16.8.3.2.3. By End User
  • 16.8.4. U.K. Market Analysis
    • 16.8.4.1. Introduction
    • 16.8.4.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.4.2.1. By Product
      • 16.8.4.2.2. By Artery
      • 16.8.4.2.3. By End User
  • 16.8.5. Spain Market Analysis
    • 16.8.5.1. Introduction
    • 16.8.5.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.5.2.1. By Product
      • 16.8.5.2.2. By Artery
      • 16.8.5.2.3. By End User
  • 16.8.6. BENELUX Market Analysis
    • 16.8.6.1. Introduction
    • 16.8.6.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.6.2.1. By Product
      • 16.8.6.2.2. By Artery
      • 16.8.6.2.3. By End User
  • 16.8.7. Russia Market Analysis
    • 16.8.7.1. Introduction
    • 16.8.7.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.7.2.1. By Product
      • 16.8.7.2.2. By Artery
      • 16.8.7.2.3. By End User

17. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

• 17.1. Introduction
• 17.2. Historical Market Size (US$ Bn) and Volume ('000 Units) Analysis Trend Analysis By Market Taxonomy, 2019-2023
• 17.3. Current and Future Market Size (US$ Bn) and Volume ('000 Units) Analysis and Forecast by Market Taxonomy, 2024-2033
  • 17.3.1. By Country
    • 17.3.1.1. China
    • 17.3.1.2. Japan
    • 17.3.1.3. South Korea
  • 17.3.2. By Product
  • 17.3.3. By Artery
  • 17.3.4. By End User
• 17.4. Market Attractiveness Analysis
  • 17.4.1. By Country
  • 17.4.2. By Product
  • 17.4.3. By Artery
  • 17.4.4. By End User
• 17.5. Market Trends
• 17.6. Key Market Participants - Intensity Mapping
• 17.7. Drivers and Restraints - Impact Analysis
• 17.8. Country Level Analysis & Forecast
  • 17.8.1. China Market Analysis
    • 17.8.1.1. Introduction
    • 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 17.8.1.2.1. By Product
      • 17.8.1.2.2. By Artery
      • 17.8.1.2.3. By End User
  • 17.8.2. Japan Market Analysis
    • 17.8.2.1. Introduction
    • 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 17.8.2.2.1. By Product
      • 17.8.2.2.2. By Artery
      • 17.8.2.2.3. By End User
  • 17.8.3. South Korea Market Analysis
    • 17.8.3.1. Introduction
    • 17.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 17.8.3.2.1. By Product
      • 17.8.3.2.2. By Artery
      • 17.8.3.2.3. By End User

18. South Asia Market Analysis 2019-2023 and Forecast 2024-2033

• 18.1. Introduction
• 18.2. Historical Market Size (US$ Bn) and Volume ('000 Units) Analysis Trend Analysis By Market Taxonomy, 2019-2023
• 18.3. Current and Future Market Size (US$ Bn) and Volume ('000 Units) Analysis and Forecast by Market Taxonomy, 2024-2033
  • 18.3.1. By Country
    • 18.3.1.1. India
    • 18.3.1.2. Indonesia
    • 18.3.1.3. Malaysia
    • 18.3.1.4. Thailand
    • 18.3.1.5. Rest of South Asia
  • 18.3.2. By Product
  • 18.3.3. By Artery
  • 18.3.4. By End User
• 18.4. Market Attractiveness Analysis
  • 18.4.1. By Country
  • 18.4.2. By Product
  • 18.4.3. By Artery
  • 18.4.4. By End User
• 18.5. Market Trends
• 18.6. Key Market Participants - Intensity Mapping
• 18.7. Drivers and Restraints - Impact Analysis
• 18.8. Country Level Analysis & Forecast
  • 18.8.1. India Market Analysis
    • 18.8.1.1. Introduction
    • 18.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 18.8.1.2.1. By Product
      • 18.8.1.2.2. By Artery
      • 18.8.1.2.3. By End User
  • 18.8.2. Indonesia Market Analysis
    • 18.8.2.1. Introduction
    • 18.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 18.8.2.2.1. By Product
      • 18.8.2.2.2. By Artery
      • 18.8.2.2.3. By End User
  • 18.8.3. Malaysia Market Analysis
    • 18.8.3.1. Introduction
    • 18.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 18.8.3.2.1. By Product
      • 18.8.3.2.2. By Artery
      • 18.8.3.2.3. By End User
  • 18.8.4. Thailand Market Analysis
    • 18.8.4.1. Introduction
    • 18.8.4.2. Market Analysis and Forecast by Market Taxonomy
      • 18.8.4.2.1. By Product
      • 18.8.4.2.2. By Artery
      • 18.8.4.2.3. By End User

19. Oceania Market 2019-2023 and Forecast 2024-2033

• 19.1. Introduction
• 19.2. Historical Market Size (US$ Bn) and Volume ('000 Units) Analysis Trend Analysis By Market Taxonomy, 2019-2023
• 19.3. Current and Future Market Size (US$ Bn) and Volume ('000 Units) Analysis and Forecast by Market Taxonomy, 2024-2033
  • 19.3.1. By Country
    • 19.3.1.1. Australia
    • 19.3.1.2. New Zealand
  • 19.3.2. By Product
  • 19.3.3. By Artery
  • 19.3.4. By End User
• 19.4. Market Attractiveness Analysis
  • 19.4.1. By Country
  • 19.4.2. By Product
  • 19.4.3. By Artery
  • 19.4.4. By End User
• 19.5. Market Trends
• 19.6. Key Market Participants - Intensity Mapping
• 19.7. Drivers and Restraints - Impact Analysis
• 19.8. Country Level Analysis & Forecast
  • 19.8.1. Australia Market Analysis
    • 19.8.1.1. Introduction
    • 19.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 19.8.1.2.1. By Product
      • 19.8.1.2.2. By Artery
      • 19.8.1.2.3. By End User
  • 19.8.2. New Zealand Market Analysis
    • 19.8.2.1. Introduction
    • 19.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 19.8.2.2.1. By Product
      • 19.8.2.2.2. By Artery
      • 19.8.2.2.3. By End User

20. Middle East and Africa (MEA) Market Analysis 2019-2023 and Forecast 2024-2033

• 20.1. Introduction
• 20.2. Historical Market Size (US$ Bn) and Volume ('000 Units) Analysis Trend Analysis by Market Taxonomy, 2019-2023
• 20.3. Current and Future Market Size (US$ Bn) and Volume ('000 Units) Analysis and Forecast by Market Taxonomy, 2024-2033
  • 20.3.1. By Country
    • 20.3.1.1. GCC Countries
    • 20.3.1.2. Turkiye
    • 20.3.1.3. North Africa
    • 20.3.1.4. South Africa
    • 20.3.1.5. Rest of Middle East and Africa
  • 20.3.2. By Product
  • 20.3.3. By Artery
  • 20.3.4. By End User
• 20.4. Market Attractiveness Analysis
  • 20.4.1. By Country
  • 20.4.2. By Product
  • 20.4.3. By Artery
  • 20.4.4. By End User
• 20.5. Market Trends
• 20.6. Key Market Participants - Intensity Mapping
• 20.7. Drivers and Restraints - Impact Analysis
• 20.8. Country Level Analysis & Forecast
  • 20.8.1. GCC Countries Market Analysis
    • 20.8.1.1. Introduction
    • 20.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 20.8.1.2.1. By Product
      • 20.8.1.2.2. By Artery
      • 20.8.1.2.3. By End User
    • 20.8.1.3. Turkiye Market Analysis
    • 20.8.1.4. Introduction
    • 20.8.1.5. Market Analysis and Forecast by Market Taxonomy
      • 20.8.1.5.1. By Product
      • 20.8.1.5.2. By Artery
      • 20.8.1.5.3. By End User
  • 20.8.2. South Africa Market Analysis
    • 20.8.2.1. Introduction
    • 20.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 20.8.2.2.1. By Product
      • 20.8.2.2.2. By Artery
      • 20.8.2.2.3. By End User
  • 20.8.3. North Africa Market Analysis
    • 20.8.3.1. Introduction
    • 20.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 20.8.3.2.1. By Product
      • 20.8.3.2.2. By Artery
      • 20.8.3.2.3. By End User

21. Market Structure Analysis

• 21.1. Market Analysis by Tier of Companies
• 21.2. Market Share Analysis of Top Players
• 21.3. Market Presence Analysis

22. Competition Analysis

• 22.1. Competition Dashboard
• 22.2. Competition Benchmarking
• 22.3. Competition Deep Dive
  • 22.3.1. Abbott Laboratories
    • 22.3.1.1. Overview
    • 22.3.1.2. Product Portfolio
    • 22.3.1.3. Sales Footprint
    • 22.3.1.4. Key Financials
    • 22.3.1.5. SWOT Analysis
    • 22.3.1.6. Key Developments
    • 22.3.1.7. Strategy Overview
      • 22.3.1.7.1. Marketing Strategy
      • 22.3.1.7.2. Product Strategy
      • 22.3.1.7.3. Channel Strategy
  • 22.3.2. B. Braun Melsungen AG
    • 22.3.2.1. Overview
    • 22.3.2.2. Product Portfolio
    • 22.3.2.3. Sales Footprint
    • 22.3.2.4. Key Financials
    • 22.3.2.5. SWOT Analysis
    • 22.3.2.6. Key Developments
    • 22.3.2.7. Strategy Overview
      • 22.3.2.7.1. Marketing Strategy
      • 22.3.2.7.2. Product Strategy
      • 22.3.2.7.3. Channel Strategy
  • 22.3.3. Biotronik SE & Co. KG
    • 22.3.3.1. Overview
    • 22.3.3.2. Product Portfolio
    • 22.3.3.3. Sales Footprint
    • 22.3.3.4. Key Financials
    • 22.3.3.5. SWOT Analysis
    • 22.3.3.6. Key Developments
    • 22.3.3.7. Strategy Overview
      • 22.3.3.7.1. Marketing Strategy
      • 22.3.3.7.2. Product Strategy
      • 22.3.3.7.3. Channel Strategy
  • 22.3.4. Boston Scientific Corporation
    • 22.3.4.1. Overview
    • 22.3.4.2. Product Portfolio
    • 22.3.4.3. Sales Footprint
    • 22.3.4.4. Key Financials
    • 22.3.4.5. SWOT Analysis
    • 22.3.4.6. Key Developments
    • 22.3.4.7. Strategy Overview
      • 22.3.4.7.1. Marketing Strategy
      • 22.3.4.7.2. Product Strategy
      • 22.3.4.7.3. Channel Strategy
  • 22.3.5. Cook Medical, Inc.
    • 22.3.5.1. Overview
    • 22.3.5.2. Product Portfolio
    • 22.3.5.3. Sales Footprint
    • 22.3.5.4. Key Financials
    • 22.3.5.5. SWOT Analysis
    • 22.3.5.6. Key Developments
    • 22.3.5.7. Strategy Overview
      • 22.3.5.7.1. Marketing Strategy
      • 22.3.5.7.2. Product Strategy
      • 22.3.5.7.3. Channel Strategy
  • 22.3.6. Cardinal Health, Inc.
    • 22.3.6.1. Overview
    • 22.3.6.2. Product Portfolio
    • 22.3.6.3. Sales Footprint
    • 22.3.6.4. Key Financials
    • 22.3.6.5. SWOT Analysis
    • 22.3.6.6. Key Developments
    • 22.3.6.7. Strategy Overview
      • 22.3.6.7.1. Marketing Strategy
      • 22.3.6.7.2. Product Strategy
      • 22.3.6.7.3. Channel Strategy
  • 22.3.7. iVascular SLU
    • 22.3.7.1. Overview
    • 22.3.7.2. Product Portfolio
    • 22.3.7.3. Sales Footprint
    • 22.3.7.4. Key Financials
    • 22.3.7.5. SWOT Analysis
    • 22.3.7.6. Key Developments
    • 22.3.7.7. Strategy Overview
      • 22.3.7.7.1. Marketing Strategy
      • 22.3.7.7.2. Product Strategy
      • 22.3.7.7.3. Channel Strategy
  • 22.3.8. Medtronic Plc.
    • 22.3.8.1. Overview
    • 22.3.8.2. Product Portfolio
    • 22.3.8.3. Sales Footprint
    • 22.3.8.4. Key Financials
    • 22.3.8.5. SWOT Analysis
    • 22.3.8.6. Key Developments
    • 22.3.8.7. Strategy Overview
      • 22.3.8.7.1. Marketing Strategy
      • 22.3.8.7.2. Product Strategy
      • 22.3.8.7.3. Channel Strategy
  • 22.3.9. Terumo Corporation
    • 22.3.9.1. Overview
    • 22.3.9.2. Product Portfolio
    • 22.3.9.3. Sales Footprint
    • 22.3.9.4. Key Financials
    • 22.3.9.5. SWOT Analysis
    • 22.3.9.6. Key Developments
    • 22.3.9.7. Strategy Overview
      • 22.3.9.7.1. Marketing Strategy
      • 22.3.9.7.2. Product Strategy
      • 22.3.9.7.3. Channel Strategy
  • 22.3.10. W. L. Gore & Associates Inc.
    • 22.3.10.1. Overview
    • 22.3.10.2. Product Portfolio
    • 22.3.10.3. Sales Footprint
    • 22.3.10.4. Key Financials
    • 22.3.10.5. SWOT Analysis
    • 22.3.10.6. Key Developments
    • 22.3.10.7. Strategy Overview
      • 22.3.10.7.1. Marketing Strategy
      • 22.3.10.7.2. Product Strategy
      • 22.3.10.7.3. Channel Strategy

23. Assumptions and Acronyms Used

24. Research Methodology

관련자료